Source comparison
Thymosin Alpha-1 Stability in Lyophilised vs Reconstituted Form
Thymosin Alpha-1, a 28-amino-acid peptide derived from thymopoietin, is supplied as lyophilised powder specifically because the freeze-dried form is dramatically more stable than aqueous solution. Lyophilisation removes water through sublimation under vacuum,
This comparison does not assign a generated winner or score.
- Thymosin Alpha-1, a 28-amino-acid peptide derived from thymopoietin, is supplied as lyophilised powder specifically because the freeze-dried form is dramatically more stable than aqueous solution. Lyophilisation removes water through sublimation under vacuum, which arrests the hydrolytic degradation pathways that would otherwise cleave peptide bonds in solution. Under continuous storage at −20°C, lyophilised Thymosin Alpha-1 retains structural integrity and immunomodulatory bioactivity for 18–24 months from the date of manufacture, as verified by high-performance liquid chromatography (HPLC) purity testing conducted at multiple timepoints.
- Once reconstituted with bacteriostatic water. Typically 0.9% benzyl alcohol in sterile water. The peptide enters an aqueous environment where degradation accelerates. Benzyl alcohol extends microbial sterility but does not prevent peptide bond hydrolysis, oxidation of methionine residues, or deamidation of asparagine and glutamine. At refrigeration temperature (2–8°C), reconstituted Thymosin Alpha-1 maintains at least 90% of initial potency for 14 days. Beyond that window, degradation rates vary: some formulations remain stable for 21–28 days, while others show measurable potency loss by day 18. The variation depends on pH of the reconstitution solution, exposure to light, and frequency of vial access. Each needle puncture introduces air and potential contamination.
- Temperature is the single most critical variable. A reconstituted vial left at room temperature (20–25°C) for six hours experiences detectable degradation. At 37°C. Body temperature, or the interior of a car on a warm day. The peptide begins denaturing within two hours. Freezing reconstituted peptide is equally destructive: ice crystal formation disrupts tertiary structure, and while the peptide may appear visually unchanged upon thawing, bioactivity is permanently compromised. The rule is simple. Lyophilised form tolerates freezing; reconstituted form does not.